Microsoft WordDabrafenib GSK PSD March 13 final...docx

First Page		Document Content
Date: 2014-10-01 21:56:23 Melanoma Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Ipilimumab Dacarbazine End point of clinical trials Medicine Chemistry Oncology		Microsoft WordDabrafenib GSK PSD March 13 final...docx Add to Reading List Source URL: www.pbs.gov.au Download Document from Source Website File Size: 94,43 KB Share Document on Facebook

	Assessment RunMelan-A (MLA) Material The slide to be stained for MLA comprised: 1. Skin, 2. Kidney, 3. Adrenal gland, 4-5. Malignant melanoma, DocID: 1vjEH - View Document
	Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664 DocID: 1v2ur - View Document
	INTERNATIONAL JOURNAL OF ONCOLOGY 51: , 2017 Effects of ursolic and oleanolic on SK‑MEL‑2 melanoma cells: In vitro and in vivo assays Angela Caunii1, Camelia Oprean1,2, Mirabela Cristea2, Alexandra Ivan DocID: 1uXlM - View Document
	Assessment RunVimentin (VIM) Material The slide to be stained for VIM comprised: 1. Colon, 2. Liver, 3. Pancreas, 4. Seminoma, 5. Malignant melanoma, 6. Renal cell DocID: 1uLxz - View Document
	SKIN CANCER: SHINING LIGHT ON THE FACTS SKIN CANCER IS THE MOST COMMON CANCER IN THE U.S. Skin cancer includes basal cell carcinoma, squamous cell carcinoma, melanoma and other uncommon skin cancers. IN 2016 DocID: 1uIBn - View Document